{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:22:37Z","timestamp":1777922557704,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,30]]},"DOI":"10.7759\/cureus.14196","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T03:17:30Z","timestamp":1617160650000},"source":"Crossref","is-referenced-by-count":2,"title":["Anticoagulation in a Patient With Mechanical Prosthetic Valves and Calcific Uremic Arteriolopathy on Warfarin"],"prefix":"10.7759","author":[{"given":"Megan C","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Gleaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniruddha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015091065","article-title":"A nationally representative study of calcific uremic arteriolopathy risk factors","volume":"27","author":"Nigwekar SU","year":"2016","unstructured":"Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, Chan KE. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016, 27:3421-9. 10.1681\/ASN.2015091065","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00770208","article-title":"Vitamin K-dependent proteins, warfarin, and vascular calcification","volume":"3","author":"Danziger J","year":"2008","unstructured":"Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol. 2008, 3:1504-10. 10.2215\/CJN.00770208","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17305660","article-title":"Tracheobronchial stenosis in Keutel syndrome","volume":"17","author":"Meier M","year":"2001","unstructured":"Meier M, Weng LP, Alexandrakis E, R\u00fcschoff J, Goeckenjan G. Tracheobronchial stenosis in Keutel syndrome. Eur Respir J. 2001, 17:566-9. 10.1183\/09031936.01.17305660","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021, 143:e72-e227. 10.1161\/CIR.0000000000000923","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13685","article-title":"Direct oral anticoagulant medications in calciphylaxis","volume":"56","author":"King BJ","year":"2017","unstructured":"King BJ, El-Azhary RA, McEvoy MT, Shields RC, McBane RD, McCarthy JT, Davis MDP. Direct oral anticoagulant medications in calciphylaxis. Int J Dermatol. 2017, 56:1065-70. 10.1111\/ijd.13685","journal-title":"Int J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes RD","year":"2010","unstructured":"Lopes RD, Alexander JH, Al-Khatib SM, et al.. Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J. 2010, 159:331-9. 10.1016\/j.ahj.2009.07.035","journal-title":"Am Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom JW","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M, et al.. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013, 369:1206-14. 10.1056\/NEJMoa1300615","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.4821","article-title":"Warfarin-associated nonuremic calciphylaxis","volume":"153","author":"Yu WY","year":"2017","unstructured":"Yu WY, Bhutani T, Kornik R, Pincus LB, Mauro T, Rosenblum MD, Fox LP. Warfarin-associated nonuremic calciphylaxis. JAMA Dermatol. 2017, 153:309-14. 10.1001\/jamadermatol.2016.4821","journal-title":"JAMA Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons","volume":"140","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019, 140:e125-e151. 10.1161\/CIR.0000000000000665","journal-title":"Circulation"},{"key":"ref10","article-title":"Anticoagulation management of valve replacement patients","volume":"11","author":"Ezekowitz MD","year":"2002","unstructured":"Ezekowitz MD. Anticoagulation management of valve replacement patients. J Heart Valve Dis. 2002, 11:56-60.","journal-title":"J Heart Valve Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55468-anticoagulation-in-a-patient-with-mechanical-prosthetic-valves-and-calcific-uremic-arteriolopathy-on-warfarin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:18Z","timestamp":1707507078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55468-anticoagulation-in-a-patient-with-mechanical-prosthetic-valves-and-calcific-uremic-arteriolopathy-on-warfarin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.14196","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}